Accendra Health, Inc. Excess of Replacement or Current Costs over Stated LIFO Value
Accendra Health, Inc. (ACH) had Excess of Replacement or Current Costs over Stated LIFO Value of $234.00 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Inventory › LIFO Method Related Items
us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue · last filed 2025-02-28
- 2024-12-31: Excess of Replacement or Current Costs over Stated LIFO Value $234.00M.
- 2023-12-31: Excess of Replacement or Current Costs over Stated LIFO Value $233.00M.
- 2022-12-31: Excess of Replacement or Current Costs over Stated LIFO Value $231.00M.
- 2021-12-31: Excess of Replacement or Current Costs over Stated LIFO Value $225.00M.
| Period end | Excess of Replacement or Current Costs over Stated LIFO Value | Excess of Replacement or Current Costs over Stated LIFO Value as first filed |
|---|---|---|
| 2024-12-31 | $234.00M 10-K · filed 2025-02-28 | |
| 2023-12-31 | $233.00M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $231.00M 10-K · filed 2024-02-20 | |
| 2021-12-31 | $225.00M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $170.00M 10-K · filed 2022-02-23 | |
| 2019-12-31 | $155.00M 10-K · filed 2021-02-24 | $154.70M 10-K · filed 2020-03-04 |
| 2018-12-31 | $146.50M 10-K · filed 2020-03-04 | |
| 2017-12-31 | $119.60M 10-K · filed 2019-03-06 | |
| 2016-12-31 | $115.40M 10-K · filed 2018-02-23 | |
| 2015-12-31 | $116.40M 10-K · filed 2017-02-17 | |
| 2014-12-31 | $116.20M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $108.60M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $110.90M 10-K · filed 2014-02-25 | |
| 2011-12-31 | $106.70M 10-K · filed 2013-02-22 | |
| 2010-12-31 | $93.00M 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |